At the time of writing, Twist Bioscience Corp [TWST] stock is trading at $32.81, up 5.26%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TWST shares have gain 3.50% over the last week, with a monthly amount glided 9.15%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Twist Bioscience Corp [NASDAQ: TWST] stock has seen the most recent analyst activity on November 04, 2025, when Stephens initiated its Overweight rating and assigned the stock a price target of $41. Previously, Wolfe Research started tracking the stock with Outperform rating on December 13, 2024, and set its price target to $60. On June 04, 2024, Guggenheim initiated with a Buy rating and assigned a price target of $53 on the stock. Goldman upgraded its rating to a Buy and increased its price target to $45 on January 17, 2024. Berenberg initiated its recommendation with a Buy and recommended $27 as its price target on September 27, 2023. Scotiabank started tracking with a Sector Outperform rating for this stock on January 05, 2023, and assigned it a price target of $33. In a note dated January 03, 2023, Evercore ISI upgraded an Outperform rating on this stock and boosted its target price from $28 to $36.
For the past year, the stock price of Twist Bioscience Corp fluctuated between $23.30 and $55.33. Currently, Wall Street analysts expect the stock to reach $42.33 within the next 12 months. Twist Bioscience Corp [NASDAQ: TWST] shares were valued at $32.81 at the most recent close of the market. An investor can expect a potential return of 29.02% based on the average TWST price forecast.
Analyzing the TWST fundamentals
According to Twist Bioscience Corp [NASDAQ:TWST], the company’s sales were 376.57M for trailing twelve months, which represents an 16.88% jump. Gross Profit Margin for this corporation currently stands at 0.51% with Operating Profit Margin at -0.36%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.21%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.17 and Total Capital is -0.25. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 31.08 points at the first support level, and at 29.36 for the second support level. However, for the 1st resistance point, the stock is sitting at 33.87, and for the 2nd resistance point, it is at 34.94.
Ratios To Look Out For
It is important to note that Twist Bioscience Corp [NASDAQ:TWST] has a current ratio of 3.64. As well, the Quick Ratio is 3.33, while the Cash Ratio is 2.0. Considering the valuation of this stock, the price to sales ratio is 5.33, the price to book ratio is 4.21.
Transactions by insiders
Recent insider trading involved Cho Dennis, that happened on Nov 21 ’25 when 757.0 shares were sold. President and COO, Finn Patrick John completed a deal on Nov 21 ’25 to sell 1776.0 shares. Meanwhile, SVP of Human Resources Green Paula sold 598.0 shares on Nov 21 ’25.
